DRUGS & SUPPLEMENTS

Deprizac

Name: Deprizac drug & pharmaceuticals. Deprizac available forms, doses, prices
Creator: sdrugs.com
Published: 2021-11-11T10:10:10+00:00

How is the drug helping you?

Deprizac uses

Pharmacological action
Pharmacokinetics
Why is Deprizac prescribed?
Dosage and administration
Deprizac side effects, adverse reactions
Deprizac contraindications
Using during pregnancy and breastfeeding
Special instructions
Deprizac drug interactions
Deprizac in case of emergency / overdose
Deprizac reviews

Pharmacological action

Deprizac is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Deprizac is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Deprizac apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Deprizac does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.

Pharmacokinetics

Deprizac absorbed from the gastrointestinal tract. This medication is poorly metabolized in the "first pass" through the liver. The ingestion did not affect the extent of absorption, although it may slow its speed. C_max in plasma is reached after 6-8 hours. C_ss in plasma is reached only after a continuous reception in a few weeks. The protein binding is 94.5%. Deprizac easily penetrates through the BBB.

Deprizac metabolized in the liver by demethylation to form the main active metabolite norfluoxetine.

T_1/2 of Deprizac is 2-3 days, norfluoxetine - 7-9 days.

Why is Deprizac prescribed?

Depressions of various origins, obsessive-compulsive disorders, bulimic neurosis.

Dosage and administration

The initial dose of Deprizac is 20 mg 1 time / day in the morning, if necessary, the dose may be increased in 3-4 weeks. The frequency of reception is 2-3 times / day.

The maximum oral daily dose for adults is 80 mg.

Deprizac side effects, adverse reactions

CNS: anxiety, tremors, nervousness, drowsiness, headache, sleep disturbances.

Digestive system: diarrhea, nausea.

Metabolism: increased sweating, hypoglycemia, hyponatremia.

Reproductive system: decreased libido.

Allergic reactions: skin rash, itching.

Other: pain in joints and muscles, shortness of breath, increased body temperature.

Deprizac contraindications

Glaucoma, bladder atony, severe renal dysfunction, benign prostatic hyperplasia, co-administration of MAO inhibitors, convulsions of various origins, epilepsy, pregnancy, lactation, hypersensitivity to Deprizac.

Using during pregnancy and breastfeeding

Deprizac is contraindicated during pregnancy and lactation.

Special instructions

Deprizac should be used with caution in patients with impaired liver and kidney, with a history of epileptic seizures, cardio-vascular diseases.

Patients with diabetes may change in blood glucose levels that require correction dosing regimen of hypoglycemic drugs. When applied in debilitated patients with Deprizac increases the risk of epileptic seizures.

With the simultaneous application of Deprizac and electroconvulsive therapy may develop prolonged seizures.

Deprizac can be applied not earlier than 14 days after discontinuation of MAO inhibitors. The period after the abolition of Deprizac before therapy MAO inhibitors should not be less than 5 weeks.

Elderly patients need correction of dosing regimen.

Safety of Deprizac in children has not been established.

During the period of treatment it needed to avoid use alcohol.

During the period of treatment should refrain from potentially hazardous activities requiring increased attention and rapid psychomotor reactions.

Deprizac drug interactions

Simultaneous administration of Deprizac with:

drugs providing a depressing effect on the central nervous system and with ethanol it is possibly significantly increased inhibitory action on the CNS, as well as increasing the likelihood of developing seizures;

MAO inhibitors, furazolidone, procarbazine, tryptophan may develop serotonin syndrome ;

Deprizac inhibits the metabolism of tricyclic and tetracyclic antidepressants, trazodone, carbamazepine, diazepam, metoprolol, terfenadine, phenytoin, thereby increasing their concentration in serum, increase their therapeutic and side effects;

it is possible inhibition of the biotransformation of drugs metabolized with the participation of isoenzyme CYP2D6;

hypoglycemic agents may increase their activities;

haloperidol, fluphenazine, maprotiline, metoclopramide, perphenazine, pyrathiazine, pimozide, risperidone, sulpiride, trifluoperazine there were describes cases of extrapyramidal symptoms and dystonia; with dextromethorphan - described a case of hallucinations; with digoxin - the case of increasing the concentration of digoxin in plasma;

with lithium salts may increase or decrease the concentration of lithium in blood plasma;

may increase the concentration of imipramine and desipramine in plasma is 2-10 times (and may persist for 3 weeks after discontinuation of Deprizac Sanis Health);

propofol there was described a case in which spontaneous movements were observed; with phenylpropanolamine - described a case in which were observed dizziness, weight loss, hyperactivity;

may increase the effects of flecainide, mexiletine, propafenone, thioridazine, zuclopenthixol. There are reports on the strengthening effects of warfarin in its simultaneous application with Deprizac.

Deprizac in case of emergency / overdose

Symptoms: nausea, vomiting, agitation, restlessness, hypomania, seizures, large seizures. There were describes two deaths from acute overdose of Deprizac (in combination with maprotiline, codeine, temazepam).

Treatment: gastric lavage, taking activated charcoal, sorbitol, ECG monitoring, symptomatic and supportive therapy, when convulsions - diazepam. There is no specific antidote. Forced diuresis, peritoneal dialysis, hemodialysis, blood transfusions are ineffective.

Deprizac pharmaceutical active ingredients containing related brand and generic drugs:

Fluoxetine Hydrochloride

Deprizac available forms, composition, doses:

Capsules; Oral; Fluoxetine Hydrochloride 20 mg

Deprizac destination | category:

Human:
Antidepressants
Selective serotonin reuptake inhibitors

Deprizac Anatomical Therapeutic Chemical codes:

N06AB03 - Fluoxetine

Deprizac pharmaceutical companies:

References

Dailymed."SARAFEM (FLUOXETINE HYDROCHLORIDE) TABLET [ALLERGAN, INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
"fluoxetine". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
"fluoxetine". http://www.drugbank.ca/drugs/DB0047... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Deprizac?

Depending on the reaction of the Deprizac after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Deprizac not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Deprizac addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

Review

sdrugs.com conducted a study on Deprizac, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Deprizac consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.